Search research articles
Contact Us
Filters
Showing results (1-10 of 51) with videos related to
Page
of 6
Sort By:
Gynecologic Oncology
|
October 29, 1998
Control of cyclin D1 expression by antisense oligonucleotides in three ovarian cancer cell lines
M Cagnoli, F Barbieri, C Bruzzo, et al.
Pharmacological Research
|
February 7, 1998
Antisense oligonucleotides as therapeutic agents
A Alama, F Barbieri, M Cagnoli, et al.
Drugs Under Experimental and Clinical Research
|
January 1, 1991
The use of antisense oligodeoxynucleotides (aODNs) for the therapy of cancer
A Alama, F Barbieri, F Bottini, et al.
The International Journal of Biological Markers
|
January 1, 1987
Monoclonal antibodies to alpha DNA polymerase as a marker of cell proliferative activity
A Alama, S Ferrini, M Gaddi, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1990
Timed sequential chemotherapy following ifosfamide-induced kinetic recruitment in refractory ovarian cancer
R Rosso, A Alama, L Repetto, et al.
Cancer Research
|
April 1, 1987
Evaluation of growth fractions with monoclonal antibodies to human alpha-DNA polymerase
A Alama, A Nicolin, P F Conte, et al.
Anti-Cancer Drugs
|
October 17, 1998
Synthesis and biological activity of gold and tin compounds in ovarian cancer cells
M Cagnoli, A Alama, F Barbieri, et al.
Experimental Cell Research
|
June 1, 1993
Antiproliferative effect of DNA polymerase alpha antisense oligodeoxynucleotides on breast cancer cells
A Alama, R Meazza, F Barbieri, et al.
Antisense & Nucleic Acid Drug Development
|
January 1, 1996
Inhibition of DNA polymerase alpha expression and cell growth, a possible triple helix mechanism
A Alama, F Barbieri, M Cagnoli, et al.
Nucleic Acids Symposium Series
|
January 1, 1991
Liquid phase synthesis and evaluation of antisense oligodeoxynucleotides to DNA polymerase alpha
M Mazzei, A Balbi, E Sottofattori, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 51) with videos related to
Sort By:
Page
of 6
Gynecologic Oncology
|
October 29, 1998
Control of cyclin D1 expression by antisense oligonucleotides in three ovarian cancer cell lines
M Cagnoli, F Barbieri, C Bruzzo, et al.
Pharmacological Research
|
February 7, 1998
Antisense oligonucleotides as therapeutic agents
A Alama, F Barbieri, M Cagnoli, et al.
Drugs Under Experimental and Clinical Research
|
January 1, 1991
The use of antisense oligodeoxynucleotides (aODNs) for the therapy of cancer
A Alama, F Barbieri, F Bottini, et al.
The International Journal of Biological Markers
|
January 1, 1987
Monoclonal antibodies to alpha DNA polymerase as a marker of cell proliferative activity
A Alama, S Ferrini, M Gaddi, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1990
Timed sequential chemotherapy following ifosfamide-induced kinetic recruitment in refractory ovarian cancer
R Rosso, A Alama, L Repetto, et al.
Cancer Research
|
April 1, 1987
Evaluation of growth fractions with monoclonal antibodies to human alpha-DNA polymerase
A Alama, A Nicolin, P F Conte, et al.
Anti-Cancer Drugs
|
October 17, 1998
Synthesis and biological activity of gold and tin compounds in ovarian cancer cells
M Cagnoli, A Alama, F Barbieri, et al.
Experimental Cell Research
|
June 1, 1993
Antiproliferative effect of DNA polymerase alpha antisense oligodeoxynucleotides on breast cancer cells
A Alama, R Meazza, F Barbieri, et al.
Antisense & Nucleic Acid Drug Development
|
January 1, 1996
Inhibition of DNA polymerase alpha expression and cell growth, a possible triple helix mechanism
A Alama, F Barbieri, M Cagnoli, et al.
Nucleic Acids Symposium Series
|
January 1, 1991
Liquid phase synthesis and evaluation of antisense oligodeoxynucleotides to DNA polymerase alpha
M Mazzei, A Balbi, E Sottofattori, et al.
Page
of 6